Sentence examples for management of relapses from inspiring English sources

Costs associated with the management of relapses were estimated according to previously published relapse-related costs; it included direct treatment and informal care resource development using a costs-of-illness method [28].

In this phase generalization of learned behaviour and management of relapses will be discussed.

It also indicates that the quality of care and the clinical management of relapses and side-misuse were sometimes compromised.

Nevertheless treatment should also target secondary outcomes as the increase and maintenance of motivation, the reduction of drop-out rates and the management of relapses [ 43, 46].

This paper represents the first attempt to attribute health care expenditures in Italy to specific phases of disease, according to varying treatment approaches, surveillance strategies and management of relapses, palliative care.

We also need to identify the optimal time frame to perform the tendon transfer following initial correction of the deformity, if the transfer should be performed after the first or second relapse and the role of repeated manipulations and casting in the management of relapses.

The management of relapsing-remitting multiple sclerosis, spasticity and relapses accounted for a 6-month cost per patient of 7,078.02€ when using interferon-β and 4,671.31€ when using glatiramer acetate.

If the patient agreed, we also involved the main carer and families in the session, particularly for sessions 6, 7, and 8 (risks of treatment discontinuation and detection and management of relapse).

With respect to the higher evidence level of new substances such as bortezomib or lenalidomide, at present ATO has no role in routine management of relapsed or refractory myeloma.

In the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation, the Scientific/Educational Session on Autologous Transplantation addressed the role of novel agents and immunomodulatory strategies in management of relapse after autologous hematopoietic stem cell transplantation (AHSCT).

37 patients reported recurrence of pain and most chose CAM treatment for management of relapse symptoms.